Rosuvastatin Export Market Intelligence: India's 427 Suppliers Shipping to 143 Countries — TransData Nexus 2026

Q: Who are the top rosuvastatin exporters from India?

The top rosuvastatin exporters from India are: 1. STRIDES PHARMA SCIENCE LIMITED — $78.7M (17.0% market share); 2. MSN LABORATORIES PRIVATE LIMITED — $58.9M (12.7% market share); 3. GLENMARK PHARMACEUTICALS LIMITED — $44.3M (9.6% market share); 4. BIOCON PHARMA LIMITED — $42.0M (9.1% market share); 5. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $37.1M (8.0% market share). Together they account for 56.3% of India's total rosuvastatin export value.

Q: What is the total export value of rosuvastatin from India?

The total export value of rosuvastatin from India is $463.3M USD, recorded across 13,477 shipment transactions from 427 active exporters to 143 destination countries. The average shipment value is $34.4K.

Q: Which countries import rosuvastatin from India?

India exports rosuvastatin to 143 countries worldwide. The top importing countries are: UNITED STATES (42.3% share, $196.1M), AUSTRALIA (17.2% share, $79.8M), CANADA (6.4% share, $29.9M), NETHERLANDS (4.7% share, $21.9M), PHILIPPINES (3.8% share, $17.6M). These five markets account for 74.5% of total export value.

Q: What is the HS code for rosuvastatin exports from India?

The primary HS code for rosuvastatin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of rosuvastatin exports from India?

The average unit price for rosuvastatin exports from India is $16.52 USD per unit, with prices ranging from $0.00 to $14580.68 depending on formulation, packaging, and order volume. The total market is valued at $463.3M across 13,477 shipments.

Q: Which ports handle rosuvastatin exports from India?

The primary ports for rosuvastatin exports from India are NHAVA SHEVA SEA (INNSA1) (8.1% of shipments), SAHAR AIR (6.8% of shipments), SAHAR AIR CARGO ACC (INBOM4) (6.7% of shipments), HYDERABAD ICD (INSNF6) (6.5% of shipments), DELHI AIR CARGO ACC (INDEL4) (5.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of rosuvastatin?

India is one of the world's leading exporters of rosuvastatin due to its large base of 427 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports rosuvastatin to 143 countries, demonstrating 73% global market coverage.

Q: What certifications do Indian rosuvastatin exporters need?

Indian rosuvastatin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import rosuvastatin from India?

There are 1,314 registered buyers importing rosuvastatin from India, spread across 143 countries. The repeat buyer rate is 69.0%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top rosuvastatin supplier from India?

STRIDES PHARMA SCIENCE LIMITED is the leading rosuvastatin exporter from India with a market share of 17.0% and total export value of $78.7M across 420 shipments. The top 5 suppliers together control 56.3% of total export value.

Suresh Sormare

Rosuvastatin

India Pharmaceutical Trade Intelligence

$463.3M427 Suppliers143 CountriesHS 30049099

ExportsIndia → UNITED STATES42.3%India → AUSTRALIA17.2%

ImportsPUERTO RICO → India$1015.1B CHINA → India$980.1K

#1 Supplier: STRIDES PHARMA

Rosuvastatin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Rosuvastatin to the World

Between 2022 and 2026, India exported $463.3M worth of rosuvastatin across 13,477 verified shipments to 143 countries — covering 73% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (42.3%). STRIDES PHARMA SCIENCE LIMITED leads with a 17.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·

Rosuvastatin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Rosuvastatin export data snapshot — $463.3M · 427 exporters · 143 countriesTransData Nexus · Indian Customs Data

Top Rosuvastatin Exporters from India

427 active exporters · Ranked by export value

View all 427 →

Top Rosuvastatin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	STRIDES PHARMA SCIENCE LIMITED	$78.7M	420	3	17.0%
2	MSN LABORATORIES PRIVATE LIMITED

Top Countries Importing Rosuvastatin from India

143 destination markets · Ranked by import value

All 143 countries →

Top Countries Importing Rosuvastatin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$196.1M	42.3%
2	AUSTRALIA	$79.8M	17.2%
3	CANADA	$29.9M	6.4%
4	NETHERLANDS	$21.9M	4.7%
5	PHILIPPINES	$17.6M	3.8%
6	BRAZIL	$15.6M	3.4%
7	BELGIUM	$13.1M	2.8%
8	FRANCE	$10.9M	2.4%
9	SRI LANKA	$8.8M	1.9%
10	POLAND	$7.2M	1.6%

UNITED STATES is India's largest rosuvastatin export destination, absorbing 42.3% of total exports worth $196.1M. The top 5 importing countries — UNITED STATES, AUSTRALIA, CANADA, NETHERLANDS, PHILIPPINES — together account for 74.5% of India's total rosuvastatin export value. The remaining 138 destination countries collectively receive the other 25.5%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Rosuvastatin to India?

25 origin countries · Total import value: $1015.1B

India imports rosuvastatin from 25 countries with a combined import value of $1015.1B. The largest supplier is PUERTO RICO ($1015.1B, 43 shipments), followed by CHINA and SPAIN. All values are from Indian Customs (DGFT) import records.

Countries Supplying Rosuvastatin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	PUERTO RICO	$1015.1B	43	100.0%
2	CHINA	$980.1K	19	0.0%
3	SPAIN	$852.7K	12	0.0%
4	UNITED STATES	$36.0K	21	0.0%
5	GREECE	$25.4K	9	0.0%
6	GERMANY	$16.7K	13	0.0%
7	BRAZIL	$11.3K	21	0.0%
8	CANADA	$10.7K	49	0.0%
9	UNITED KINGDOM	$9.7K	7	0.0%
10	DENMARK	$9.4K	13	0.0%

Showing top 10 of 25 origin countries

PUERTO RICO is the largest supplier of rosuvastatin to India, accounting for 100.0% of total import value. The top 5 origin countries — PUERTO RICO, CHINA, SPAIN, UNITED STATES, GREECE — together supply 100.0% of India's rosuvastatin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Rosuvastatin — Export Intelligence Video

Visual overview of India's rosuvastatin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's rosuvastatin pharmaceutical import and export market — $463.3M in total trade, 427 verified manufacturers, and 143 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Rosuvastatin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Rosuvastatin calcium, a statin medication used to manage dyslipidemia, has been a significant component of the U.S. pharmaceutical market. The FDA approved the first generic version of rosuvastatin in April 2016, marking the end of AstraZeneca's patent exclusivity. Since then, numerous Abbreviated New Drug Applications (ANDAs) have been approved, reflecting a competitive generic landscape. As of March 2026, the FDA's Orange Book lists multiple approved ANDAs for rosuvastatin calcium tablets, indicating sustained market interest and availability.

The United States remains the primary destination for Indian exports of rosuvastatin, accounting for 42.3% of total exports. This substantial market share underscores the importance of compliance with FDA regulations, including adherence to Current Good Manufacturing Practices (cGMP) and timely reporting of adverse events. Indian exporters must ensure rigorous quality control and regulatory compliance to maintain and expand their presence in the U.S. market.

2EU & UK Regulatory Framework

In the European Union, rosuvastatin received marketing authorization through a Mutual Recognition Procedure initiated in December 2002, with the Netherlands serving as the reference member state. The European Medicines Agency (EMA) has since overseen the regulation of rosuvastatin, ensuring compliance with EU standards. Similarly, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorizations for rosuvastatin, aligning with EMA guidelines.

Manufacturers exporting rosuvastatin to the EU and UK must comply with Good Manufacturing Practice (GMP) requirements as stipulated by the EMA and MHRA. This includes regular inspections and adherence to quality standards to ensure the safety and efficacy of the product.

3WHO Essential Medicines & Global Standards

Rosuvastatin is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025. This inclusion highlights its significance in managing cardiovascular diseases globally. The WHO Model List serves as a guide for countries to develop their national essential medicines lists, promoting access to vital medications.

Regarding pharmacopoeial standards, rosuvastatin is listed in major compendia, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards ensures the quality and consistency of rosuvastatin products across different markets.

4India Regulatory Classification

In India, rosuvastatin is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) regulates its price to ensure affordability. As of March 2026, the ceiling price for rosuvastatin 10 mg tablets is set at ₹10.50 per tablet, as per the latest NPPA notification.

For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products. While rosuvastatin is generally permitted for export, exporters must ensure compliance with DGFT regulations and obtain necessary clearances to facilitate smooth international trade.

5Patent & Exclusivity Status

The primary patent for rosuvastatin (RE37,314) expired in 2016, leading to the approval of generic versions by the FDA in April 2016. This expiration has resulted in increased generic competition, benefiting consumers through reduced prices and improved accessibility.

6Recent Industry Developments

In April 2025, the WHO launched the National Essential Medicines Lists (nEMLs) repository, a centralized digital platform compiling 150 national essential medicines lists. This initiative aims to enhance access to critical healthcare data, supporting policymakers and healthcare professionals in decision-making processes. (who.int)

In September 2025, the WHO published the 24th edition of the Model List of Essential Medicines, reaffirming the inclusion of rosuvastatin. This underscores its continued importance in global health strategies for managing cardiovascular diseases. (who.int)

These developments reflect ongoing efforts by international health organizations to standardize and improve access to essential medicines, including rosuvastatin, thereby influencing global trade and regulatory landscapes.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Rosuvastatin

Retail & reference prices across 9 markets vs. India FOB export price of $16.52/unit

Global Price Benchmark for Rosuvastatin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.27	USD	According to the FDA Orange Book, generic versions of Rosuvastatin have been approved, leading to competitive pricing in the U.S. market.
United Kingdom	$0.27	GBP	The NHS Drug Tariff lists Rosuvastatin 10 mg tablets, with prices subject to periodic updates by the Department of Health and Social Care.
Germany	$0.28	EUR	The Federal Joint Committee (G-BA) in Germany includes Rosuvastatin in its list of reimbursable medications, with pricing influenced by negotiations between statutory health insurance funds and pharmaceutical manufacturers.

Supply Chain Risk Assessment — Rosuvastatin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, renowned as the "pharmacy of the world," heavily relies on China for Key Starting Materials (KSMs) essential in Active Pharmaceutical Ingredient (API) production. Approximately 70% of APIs and KSMs are imported from China, underscoring a significant supply chain vulnerability. This dependency is particularly concerning for drugs like Rosuvastatin, where the synthesis process is contingent upon the availability of specific KSMs.

The COVID-19 pandemic in early 2020 exposed the fragility of this reliance. Disruptions in Chinese manufacturing led to shortages of critical APIs, including those for widely used medications. In response, the Indian government initiated the Production Linked Incentive (PLI) scheme in February 2021, allocating ₹6,940 crore to bolster domestic production of 53 identified APIs and KSMs. Despite these efforts, as of December 2023, imports from China continued to grow, indicating that the PLI scheme's impact is gradual and the industry still faces challenges in achieving self-reliance.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 reveals that the top five Indian exporters of Rosuvastatin account for 56.3% of total exports, with STRIDES PHARMA SCIENCE LIMITED leading at a 17.0% share. This concentration indicates a moderate risk, as disruptions affecting these key suppliers could significantly impact global Rosuvastatin availability.

Access Complete Rosuvastatin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 13,477 transactions across 143 markets.

Request Demo View Pricing

Frequently Asked Questions — Rosuvastatin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top rosuvastatin exporters from India?

The leading rosuvastatin exporters from India are STRIDES PHARMA SCIENCE LIMITED, MSN LABORATORIES PRIVATE LIMITED, GLENMARK PHARMACEUTICALS LIMITED, and 12 others. STRIDES PHARMA SCIENCE LIMITED leads with 17.0% market share ($78.7M). The top 5 suppliers together control 56.3% of total export value.

What is the total export value of rosuvastatin from India?

The total export value of rosuvastatin from India is $463.3M, recorded across 13,477 shipments from 427 active exporters to 143 countries. The average shipment value is $34.4K.

Which countries import rosuvastatin from India?

India exports rosuvastatin to 143 countries. The top importing countries are UNITED STATES (42.3%), AUSTRALIA (17.2%), CANADA (6.4%), NETHERLANDS (4.7%), PHILIPPINES (3.8%), which together account for 74.5% of total export value.

What is the HS code for rosuvastatin exports from India?

The primary HS code for rosuvastatin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Rosuvastatin

Rosuvastatin

Top Rosuvastatin Exporters from India

Top Countries Importing Rosuvastatin from India

Who Supplies Rosuvastatin to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Rosuvastatin — Export Intelligence Video

Regulatory Landscape — Rosuvastatin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Rosuvastatin

Supply Chain Risk Assessment — Rosuvastatin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Rosuvastatin Trade Intelligence

Frequently Asked Questions — Rosuvastatin Exports from India

Who are the top rosuvastatin exporters from India?

What is the total export value of rosuvastatin from India?

Which countries import rosuvastatin from India?

What is the HS code for rosuvastatin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of rosuvastatin exports from India?

Which ports handle rosuvastatin exports from India?

Why is India a leading exporter of rosuvastatin?

What certifications do Indian rosuvastatin exporters need?

How many buyers import rosuvastatin from India?

What is the market share of the top rosuvastatin exporter from India?

Analysis Methodology